中文 | English
Return
Total: 12 , 1/2
Show Home Prev Next End page: GO
Author:(Yaojuan CHU)

1.Simultaneous determination of eight constituents in Xuebijing Injection by UPLC-MS/MS

Zhi SUN ; Juntao FU ; Lin ZHOU ; Yaojuan CHU ; Gaoxing QIAO ; Shuzhang DU

Chinese Traditional Patent Medicine 2017;39(6):1183-1187

2.Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data

Xi YANG ; Yaojuan CHU ; Juanjuan CHEN ; Ting YANG ; Chong LIU ; Rui ZHANG ; Shuzhang DU

Cancer Research on Prevention and Treatment 2021;48(10):963-969

3.Visualization Analysis of the Literatures on Drug-induced Kidney Injury

Yuanxia ZHAO ; Yaojuan CHU ; Xiaojing LU ; Xiangfen SHI ; Shuzhang DU

China Pharmacy 2021;32(15):1818-1824

4.Analysis of working pressure for return-working postpartum hospital pharmacists and its influential factors

Rui ZHANG ; Xiangde ZHAO ; Yaojuan CHU ; Jie HAO ; Xiaojuan WANG ; Shuzhang DU

China Pharmacy 2022;33(24):3059-3062

5.Research hotspots and trends on potentially inappropriate medication from 2012 to 2021

Gaoxing QIAO ; Yaojuan CHU ; Chong LIU ; Shujuan WANG ; Kefeng LIU ; Shuzhang DU

China Pharmacy 2023;34(3):370-375

6.Improvement effect and mechanism of matrine on experimental autoimmune encephalomyelitis mice

Xinyu LI ; Yaojuan CHU ; Mengmeng DOU ; Rui MA ; Silu LI ; Lin ZHU

China Pharmacy 2023;34(10):1177-1181

7.Document Visualization Analysis of Inhalation Therapy for Respiratory Diseases

Chong LIU ; Gaoxing QIAO ; Yaojuan CHU ; Ran SU ; Jie ZHAO ; Shuzhang DU

China Pharmacy 2020;31(13):1622-1627

8.Visual analysis of tyrosine kinase inhibitors in HER2 positive breast cancer

Jing ZOU ; Yaojuan CHU ; Qiuzheng DU ; Heying YUE ; Xiaobao WANG ; Shuzhang DU

China Pharmacy 2023;34(24):3036-3041

9.Analysis of the situation ,influential factors and their relationship of hospital pharmacy managers ’servant leadership behavior and hospital pharmacists ’job satisfaction

Yaojuan CHU ; Zhao YIN ; Yan LIANG ; Rui ZHANG ; Gaoxing QIAO ; Jie HAO ; Chong LIU ; Ting YANG ; Shuzhang DU

China Pharmacy 2022;33(3):366-371

10.Clinical observation of 9 cases of rituximab followed by belimumab in the treatment of severe systemic lupus erythematosus

Yuanxia ZHAO ; Guanmin GAO ; Xiaojing LU ; Yaojuan CHU ; Song WANG ; Xiangfen SHI ; Shuzhang DU ; Xiaojian ZHANG

China Pharmacy 2023;34(7):849-853

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 12 , 1/2 Show Home Prev Next End page: GO